Method to represent the nucleotide elements of dna as numerical elements to include adenine being assigned the value zero, guanine being assigned the value one, cytosine being assigned the value two and thymine being assigned the value three
US2015227683A1
Method to represent the nucleotide elements of a dna sequence as numerical elements to include cytosine being assigned the value one, thymine being assigned the value two, adenine being assigned the value three, and guanine being assigned the value four
US2015227684A1
Method to represent the nucleotide elements of a dna sequence as numerical elements to include cytosine being assigned the value zero, thymine being assigned the value one, adenine being assigned the value two and guanine being assigned the value three
US2015227678A1
Method to represent the nucleotide elements of a dna sequence as numerical elements to include adenine being assigned the value one, guanine being assigned the value two, cytosine being assigned the value three, and thymine being assigned the value four
US2011293693A1
Quantum unit of inheritance vector therapy
US2011294996A1
Quantum unit of inheritance
US2011293694A1
Quantum unit of inheritance vector therapy method
US2011236483A1
Rna vector therapy
US2011237653A1
Rna vector therapy method
US2011236466A1
Chemo vector therapy to deliver chemotherapy molecules to specific cells to manage breast cancer, other cancers and inflammatory disorders
US2011212177A1
Configurable microscopic medical payload delivery device to deliver medically therapeutic payloads to specifically targeted cell types
US2011212160A1
Configurable microscopic medical payload delivery device to deliver nuclear signaling proteins to specific cells to manage diabetes mellitus and genetic deficiency disorders
US2009297484A1
Method for curing and preventing acquired immune deficiency syndrome by altering cell-surface receptors in precursor t-helper cells and mature t-helper cells to prevent human immunodeficiency virus virions access to mature helper cells
US2009291118A1
Universal barrier to prevent infections from human immunodeficiency virus
US2009291117A1
Female barrier to prevent infections from human immunodeficiency virus
US2009292233A1
Anti-human immunodeficiency virus surrogate target agent technology filter intended to terminate t-helper cells infected with the human immunodeficiency virus circulating in blood
US2009281473A1
Anti-Human Immunodeficiency Virus Surrogate Target Agent Technology Filter Intended to Neutralize or Remove Human Immunodeficiency Virus Virions From Blood
US2009258879A1
Method for treating cancer, rheumatoid arthritis and other medical diseases by utilizing modified virus virions to insert medications into targeted cells
US2009257998A1
Method for treating heart attacks, strokes and diabetic crisis by utilizing modified virus virions to insert necessary protein molecules and vital nutrients into targeted cells
US2009257983A1
Medical treatment device for treating aids by utilizing modified human immunodeficiency virus virions to insert anti-viral medications into t-helper cells
